⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of United BioPharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
United BioPharma
↗Hukou, Taiwan
United BioPharma (UBP) is a Taiwan-based biopharmaceutical company focused on the research, development, and manufacturing of innovative monoclonal antibody (mAb) therapeutics. The company specializes in addressing significant unmet medical needs in areas such as infectious diseases, immunology, and oncology, leveraging its proprietary antibody platform technologies.
UBP operates state-of-the-art cGMP manufacturing facilities in Hsinchu, Taiwan, designed for commercial-scale production. The company is part of a broader group of affiliated entities, including United Biomedical, and maintains a strong focus on vertical integration, from early-stage drug discovery to commercial manufacturing and CDMO services.
CLASSIFICATION
SIZE & FINANCIALS
Employees:101-250
Founded:2013
Ownership:private
Status:operating
PIPELINE
Stage:Phase 2/3
Lead Drug Stage:Phase 3
Modalities:Monoclonal antibody
Active Trials:16
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:United Biomedical
Key Partnerships:GE Healthcare (Manufacturing platform), Yangzhou High Technology Industry Park (Manufacturing facility collaboration)
COMPETITION
Position:Niche Player
Competitors:Novartis, Celldex Therapeutics, Amneal Pharmaceuticals, Yuhan Corporation
LEADERSHIP
Key Executives:
James Chui - Founder
Chang Yi Wang - Chairperson
LINKS
Website:ubp.tw
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with United BioPharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.